Murine embryonic stem cells are able t o differentiate into embryoid bodies (EBs) in vitro in the absence of leukemiainhibitory factor with the formation of different types of hematopoietic precursors within these EBs. With the aim of determining the in vitro requirements for the continued development of hematopoietic colony-forming cells (CFCs) and their progeny from embryonic stem-derived cells, cells from EBs disrupted after 9 days of formation in the absence of leukemia-inhibitow factor werecultured under different conditions. Low numbers of day-9 EB cells (5 x lo5 or less1 cultured in the presence of several growth factors , IL-l, c-kit ligand, basic fibroblast growth factor, insulin growth factor-l, IL-6, granulocyte colony-stimulating factor, fetal liver kinase-2 ligand) develop few or no CFCs after 1 week of culture. When these cells are plated on irradi-VARIETY OF FUNCTIONAL blood cell types are constantly produced in vertebrate organisms from embryonic throughout adult life. In mammals, the first hematopoietic cells appear in the yolk sac. In mice, this happens from day 7 to day 13 of differentiation, when blood islands containing primitive nucleated erythrocytes can be observed. These hematopoietic cells are thought to originate from multipotent stem cells'.' because in vitro they can generate a variety of hematopoietic cell types3*'; however, in vivo differentiation appears restricted to the erythroid lineage. The origin and regulation of embryonic hematopoietic stem cells remains unknown, and the low abundance of these cells at this stage makes them difficult to isolate for study. The recently described aorta, gonad, mesonephros region contains cells with seemingly higher spleen colony-forming units (CFU-S) and long-term repopulating ability than do day-10 to -1 1 yolk sac cells.5 As development proceeds to the fetal stage, the major site of hematopoiesis shifts to the liver. Anucleate erythrocytes containing adult hemoglobin are produced exclusively by this organ and are released into the circulation. At day 16 to 17 of gestation, spleen and bone marrow become the major hematopoietic organs and remain so into adult life.
Murine embryonic stem cells are able t o differentiate into embryoid bodies (EBs) in vitro in the absence of leukemiainhibitory factor with the formation of different types of hematopoietic precursors within these EBs. With the aim of determining the in vitro requirements for the continued development of hematopoietic colony-forming cells (CFCs) and their progeny from embryonic stem-derived cells, cells from EBs disrupted after 9 days of formation in the absence of leukemia-inhibitow factor werecultured under different conditions. Low numbers of day-9 EB cells (5 x lo5 or less1 cultured in the presence of several growth factors (interleukin-3 [IL-3], IL-l, c-kit ligand, basic fibroblast growth factor, insulin growth factor-l, IL-6, granulocyte colony-stimulating factor, fetal liver kinase-2 ligand) develop few or no CFCs after 1 week of culture. When these cells are plated on irradi-VARIETY OF FUNCTIONAL blood cell types are constantly produced in vertebrate organisms from embryonic throughout adult life. In mammals, the first hematopoietic cells appear in the yolk sac. In mice, this happens from day 7 to day 13 of differentiation, when blood islands containing primitive nucleated erythrocytes can be observed. These hematopoietic cells are thought to originate from multipotent stem cells'.' because in vitro they can generate a variety of hematopoietic cell types3*'; however, in vivo differentiation appears restricted to the erythroid lineage. The origin and regulation of embryonic hematopoietic stem cells remains unknown, and the low abundance of these cells at this stage makes them difficult to isolate for study. The recently described aorta, gonad, mesonephros region contains cells with seemingly higher spleen colony-forming units (CFU-S) and long-term repopulating ability than do day-10 to -1 1 yolk sac cells. 5 As development proceeds to the fetal stage, the major site of hematopoiesis shifts to the liver. Anucleate erythrocytes containing adult hemoglobin are produced exclusively by this organ and are released into the circulation. At day 16 to 17 of gestation, spleen and bone marrow become the major hematopoietic organs and remain so into adult life.
Embryonic and fetal hematopoietic development appears to be reflected by in vitro differentiation of embryonic stem (ES) cells. ES cell lines have been derived from the inner cell mass of mouse blastocysts at day 3 of differentiation.' In the presence of leukemia-inhibitory factor (LIF) or feeder cell layers, these cells are maintained in an undifferentiated state'; in their absence, they differentiate into embryoid bodies (EBs). These EBs have been shown to contain endodermal, ectodermal, and mesodermal elements including blood islands and cardiac muscle. They have also been shown to contain hematopoietic progenitors including mixed CFU (CFU-MIX), granulocyte-macrophage CFU (Cm-GM), and erythroid burst-forming units (BFU-E), which appear in a temporal pattern similar to that observed in the early yolk sac and fetal liver. ated NIH-3T3 with IL-3 or c-kit ligand or combinations containing these and other growth factors, they are able t o generate CFCs for at least 3 weeks. These cultures were found t o include granulocytic, monocytic, erythrocytic, and megakaryocytic cells. Transwell cultures in which NIH-3T3 cells were separated from the EB cells and cultures in which cells were replaced by NIH-3T3 conditioned medium showed that the interaction between EB-derived cells and NIH-3T3 is via a soluble factor(s). These studies show that maximal generation of hematopoietic CFCs from precursors present in day-9 EBs is stimulated by a combination of known hematopoietic growth factors and a soluble factor(s1 produced by NIH-3T3 cells. repopulating ability when injected into mice." Nevertheless, fetal liver cells from ES cell-tetraploid embryo chimeras are able to reconstitute the hematopoietic system of irradiated mice," showing that ES cells are potentially able to become hematopoietic stem cells when placed in the appropriate microenvironment.
We have investigated the presence within the EBs of more primitive hematopoietic cells that are precursors of colonyforming cells (CFCs) to create an in vitro model for the regulation of these cells. We found that cells derived from EBs are unable to survive in the presence of a combination of known growth factors including interleukin-3 (IL-3), IL-1, IL-6, c-kit ligand (m), basic fibroblast growth factor (bFGF), insulin growth factor-l (IGF-l), granulocyte colony-stimulating factor (G-CSF), and fetal liver kinase-2 (flk2) ligand. When cocultured on irradiated NIH-3T3 cells, they can proliferate, differentiate, and give rise to an increased number of CFCs. This effect appears to be mediated by a soluble factor(s). dium supplemented with LIF (IO' U/mL), 15% fetal bovine serum (FBS), and 1.5 X monothioglycerol (MTG). NIH-3T3 cells'4 were maintained in Dulbecco's supplemented with glutamine, NaPyr and 10% fetal calf serum at 37°C.
Growfh factors. Recombinant murine LIF (IO3 U/mL), flk2 ligand (100 ng/mL), human IL-3 (10 ng/mL), IL-la (10 ng/mL), and L -6 (100 ng/mL) were provided by Immunex (Seattle, WA). Recombinant human KL (250 ng/mL), human erythropoietin (4 U/ mL), and G-CSF (100 ng/mL) were obtained from Amgen (Thousand Oaks, CA). Recombinant human bFGF (100 ng/mL) and IGF-1 (10 ng/mL) were purchased from Collaborative Biomedical (Bedford, MA).
Monoclonal antibodies (MoAbs). To determine the phenotype of the cells obtained after some days of culture, we stained the cells with different rat-antimouse MoAbs. B220 (RA36B2), mac-l (MI/ 70), Gr-l (RB6-8C5), CD2 (RM2.2), TER119, sca-l (E13161-6.7), AA4.1 were kindly provided by Dr G.J. Spangrude (National Institutes of Health, Hamilton, MO). 3CI (c-kit) and rat IgG2a and IgG2b were purchased from Pharmingen (San Diego, CA).
Differentiation of ES cells. We used the method described by Wiles and Keller' for the differentiation of the ES cells with slight modifications. Trypzinized ES cells were cultured in 0.8% methylcellulose (Terry Fox, Vancouver, Canada) in Iscove's modified Dulbecco's medium (IMDM) supplemented with 30% plasma-derived FBS (Cocalico Biologicals, Reamstown, PA), 300 pL of iron-saturated human transferrin (Sigma, St Louis, MO), and a final concentration of 4.5 X MTG. A total of 1,500 cells was plated in a volume of 1.5 mL in 35-mm diameter bacterial-grade dishes. Cultures were maintained at 37°C and 5% CO,.
Liquid culrures of disrupted EBs on irradiated NIH-3T3 cells. NIH-3T3 were irradiated at 30 Cy on a Cs-source and plated on 24-well plates. EBs were removed from methylcellulose by dilution with RPMI; the cells were dissociated by 2-hour incubation with 0.23% collagenase in phosphate-buffered saline with 20% fetal calf serum. Cells were gently passed through a syringe with a 20-gauge needle in the middle and at the end of this incubation. Cells were then counted and replated in 24-well plates in IMDM supplemented with 20% horse serum and m o m hydrocortisone at different concentrations and with different combinations of growth factors. Fresh growth factors were added every 3 to 4 days. Cultures were harvested every week for a period of 2 to 3 weeks by pipeting half of the supernatant out; cells obtained were counted and assayed for CFCs. In some experiments, EB-derived cells were placed on a 6.5-mm diameter transwell with a 0.4-pm pore-size collagen-treated membrane (Costar, Cambridge, MA) to avoid contact with stromal cells. Morphologic phenotype was studied by Wright-Giemsa staining and phenotypic markers were determined by flow cytometry analysis. Megakaryocytic lineage was determined by acetylcholinestarse staining.'' CFC assay. Cells were harvested from wells every week, and, whenever possible, 5,000 to 10,000 viable cells (trypan-blue exclusion) were plated in 1% methylcellulose in IMDM, 10% plasmaderived FBS (PDS), 300 pg iron-saturated transferrin, 4.5 X IO-' mom MTG, IL-3 (IO ng/mL), KL (250 ng/mL), IL-l ( I O ng/mL), G-CSF (100 ng/mL), and erythropoietin (4 UlmL). Colonies were counted at day 7, and colony types were determined by inverted microscope observation. C m -G M and CFU-MIX were corroborated at day 14.
Immunophenotypic analysis of cultured cells. Cells were incubated with several MoAbs that recognize different antigens present in myeloid, lymphoid, and erythroid lineages, as well as in more undifferentiated hematopoietic cells. Isotype-matched rat Igs were used as controls. After incubation with MoAbs, cells were stained with fluorescein isothiocyanate labeled goat antirat antibodies (Tago, Inc. Burlingame, CA). Propidium iodide (PI) staining was used to 
RESULTS

Cells derived from day-9 EBs generate large quantities
of CFCs when they are cultured in the presence of NIH-3T3 cells. With the aim of detecting a hematopoietic pre-CFCs, we disrupted EBs after several days of growth in the absence of LIF (from day 5 to day 11) and incubated the EB-derived cells in the presence of hematopoietic growth factors (IL-3, KL, and IL-1). We assessed the number of CFCs obtained after a week of culture; we did not obtain CFCs from EBs earlier than day 8 in any case (data not shown). In a few experiments, we did observe a significant increase in the number of CFCs obtained after 1 week, 2 weeks, or 3 weeks in culture when cells were derived from day-9 to IO-EBs, but only when the cells were plated at concentrations greater than 10-5 cells per well (data not shown). Because cells derived from day-9 EBs were unable to proliferate when plated at doses lower than lo5 cells per well, we sought a cell line that was able to maintain and support hematopoietic cells from EB-derived cells when plated at 5 X lo4 cells per well. In preliminary experiments, substantial numbers of CFCs were obtained when 2 to 5 X lo4 cells were plated on 3T3 in the presence of growth factors. Consequently, 5 X IO4 cells were plated in subsequent experiments. Experiments in Table 1 show that EB-derived cells cultured in the presence of irradiated NIH-3T3 cells and a combination of growth factors (IL-3, IL-I, KL, bFGF, and IGF-l) resulted in a significantly greater number of CFCs as compared with that of the control with growth factors alone ( P < .001). When cells were plated on the irradiated stromal cell lines alone, only a small number of colonies was obtained after 2 weeks of culture, but, in the presence of IL-3, IL-I , KL, bFGF, and IGF-1. a substantially greater number of CFCs was observed.
Analysis of kemaropoietic cells ohtnirted ,fiorn day-9 EB cells cultltredort irmdinted3T3 with growthfnctors. Different colony types of hematopoietic progenitors were obtained during each of 3 weeks in culture. CFU-GM were always the most common type found, but BFU-E, CFU-E, and colonies with cells from both lineages (CFU-MIX) were also present. Figure 1 shows the different types of hematopoietic colonies obtained in each week in three representative experiments in which day-9 EB cells were incubated on irradiated 3T3 cells with growth factors. Phenotypic analysis by flow cytometry of cells at IS days of culture (Fig 2) in two different experiments showed that a significant number of cells stained positively using the myeloid marker Gr-l and the macrophage marker mac-l . Markers known to be present in more immature cells including c-kit, AA4.1. and sca-l, as well as the lymphoid marker CD2. which has been shown to recognize T and B cells in mice,'" positively stained cells in one of the two experiments. However, in the experiment where the percentage of cells that stained with greater intensity than control-stained cells was insufficient to be considered positive for sca-l and CD2, a homogenous shift in the fluorescence histogram suggested a low level of expression by the cells. The B-lymphoid marker B220 and the Tlymphoid marker CD5 also showed a small homogenous shift in the fluorescence curves in one of the two experiments. Wright-Giemsa staining of cells at each week of culture showed a majority of myeloid cells at different stages of differentiation including mature neutrophils and macrophages. Different stages of erythroid differentiation were also observed. as were cells with a megakaryocytic morphology that was confirmed by acetylcholinesterase staining. by a soluble growth factor, cultures were performed on transwell membranes. Results in Table 3 show that cell-cell contact between EB cells and 3T3 cells is not necessary for the generation of CFCs from day-9 EB cells. No CFCs were obtained when cells were placed on transwells without irradiated 3T3 cells.
3T3-conditioned media stimulates proliferation hematopoietic day-9 EB-derived ceils. Supernatants obtained from irradiated NIH-3T3 cells were also able to maintain hematopoiesis by day-9 EB-derived cells for at least 2 weeks. Figure  3A shows the number of CFCs obtained each week from these cultures as compared with that for the controls. Although the number of CFCs obtained with the supernatants was lower than that in cultures in which precursors were in contact with 3T3 cells, it was significantly higher than that in cultures containing only growth factors ( P = .01). In another experiment (Fig 3B) , the supernatant alone did not show a significantly different number of CFCs from that of the control (P = .15), but the supernatant concentrated 10 times did (P = .03).
DISCUSSION
EBs are considered to have hematopoiesis equivalent to the murine yolk-sac or fetal-liver stage in normal development; little is known about the regulation of hematopoiesis at these stages, which seems to be different from the regulation of adult hematopoiesis. We have found that NIH-3T3 cells have a synergistic effect with a combination of known growth factors in generating CFCs from precursors derived from EBs. This effect appears to be mediated by a soluble factor produced by the embryonic fibroblast-like N"3T3 cells.
ES cells have proven useful in the study of hematopoie~is,8"O.'~ but their hematopoietic potential remains unclear. They have not been shown to contribute to CFU-S, and only partial contribution to murine long-term repopulation has been shown.'' In our model, markedly increased numbers of CFCs were obkined in 3 weeks of culture from precursors derived from a day-9 EB when they were placed in cultures containing irradiated NIH-3T3 cells and hematopoietic growth factors. Differentiated cells from multiple hematopoietic lineages were generated in these cultures. Phenotypic and morphologic analysis of cultured cells showed that cells with a myeloid morphology and those expressing myeloid differentiating markers were predominant. Erythroid differentiating markers were not detected, even though cells with an erythroid morphology were observed. The presence of cells with megakaryocytic morphology was confirmed by cytochemistry staining. The presence of cells comitted to lymphoid differentiation was unclear. We detected cells that expressed CD2; this antigen, which is found in both T and B cells in mice,I6 suggests that cells may have committed to lymphoid differentiation; however, cells expressing the CD5 and B220 antigens associated with more mature lymphocytes were detected at only low levels or were not detected. It is also not clear if the different types of cells found in these cultures come from a single pluripotent stem cell or from precursors committed to differentiation along a single lineage. To further investigate this question, development of single cell culture assays will be required.
Our observation that hematopoietic cell proliferation was observed in some experiments where high numbers of EBderived cells were present in the culture suggests that accessory cells present in the EB may also be able to produce this effect. However, these cells may be scarce at day 9 because large numbers of cells are necessary for the interaction to be evident. We find that 50,000 cells per well are necessary for starting the culture when cells are plated on irradiated 3T3 cells: however.
some variation was observed, and 20.000 cells is enough to initiate the culture in some experiments. The number of cells present in a single day-9 EB is much lower than that (5.000 to 12.000 cells), supporting the observation of Wiles and Keller' that only some EBs have hematopoietic differentiation. In that study, EBs were separated by size; only large EBs contained hematopoietic progenitors. Optimal serum and culture conditions are very important for ES cell differentiation," and not all the cells contribute to formation of EB.
NIH-3T3 is a fibroblast-like cell line derived from mouse embryos."l It has been shown to have an effect on murine adult bone marrow CFU-S-enriched cells and the undifferentiated hematopoietic cell line FDCP, similar to the one we have described.'".'" In these studies. the investigators report that the effect is caused by a membrane-bound factor, and cell-cell contact is necessary for the interaction to occur. In our system. we have found that NIH-3T3 cells are able to stimulate the hematopoietic proliferation and differentiation of cells derived from day-9 EBs in the transwell culture system, suggesting that secretion of one or more soluble molecules is responsible for this effect and that cell-cell interaction is not necessary. The effects of NIH-3T3 cells on adult and embryonic hematopoietic cells may, thus, be different.
We found a synergistic interaction between NIH-3T3 cells and the cytokines used in thls study. The addition of IL-3 alone to cultures containing NIH-3T3 cells results in a remarkable increase in the number of colonies produced from day-9 EBs. The addition of other hematopoietic growth factors known to act at early stages of hematopoietic differentiation also increased the number of hematopoietic progenitors obtained. The combination of IL-3. KL. IL-I. bFGF. IGF-l. IL-6. G-CSF, and flk2 ligand with NIH-3T3 resulted in the highest production of colonies after 3 weeks of culture. These factors are known to act at early stages of hematopoietic development.'"'' amplifying the number of CFCs and resulting in an increased number of CFCs when more factors are present. Even though the combination of all the factors used is enough to maintain proliferation and differentiation of early hematopoietic cells from bone it is not enough to stimulate day-9 EB-derived pre-CFCs.
It is unclear at which stage of hematopoietic development the factor(s) produced by NIH-3T3 cells contributes to the survival and proliferation of EB-derived cells. Undifferentiated ES cells do not have the capacity to become hematopoietic in our culture system. as has been reported with other methods"; cells have to differentiate as EBs for at least 8 or 9 days to be responsive to stimulation by NIH-3T3 cells. However, before day 8 to 9, it was possible to obtain CFCs mainly of the erythroid type. This may be analogous to the appearance of committed erythroid progenitors in yolk sac that may precede the appearance of long-term repopulating cells at other sites. 5 The soluble factor produced by NIH-3T3 cells may act not only on pluripotent hematopoietic cells, but on prehematopoietic committed cells. Considering the heterogeneity of the starting population, it is distinctly possible that it stimulates an accessory embryonic cell to support hematopoietic cell differentiation and proliferation. We cannot exclude the possibility that the effect we have described is caused by an already known cytokine such as IL-l1 or another that we have not tested. LIF was tested in preliminary experiments and did not seem to have any effect on the hematopoietic For personal use only. on October 30, 2017 . by guest www.bloodjournal.org From differentiation and proliferation of these cells. It is also worth considering that glycosaminoglycans or proteoglycans may be somehow involved in the regulation and proliferation of these early cells. They have been found to be important in embryonic2* and hernatopoieti~~~.~' development, sometimes acting as receptor or coreceptor for extracellular effector molecule^.^^*^* With the aim of clarifying these possibilities, further work is being performed to characterize the nature of this factor.
